Micol Cirilli

Title: Micol Cirilli: Innovator in Pharmaceutical Formulations

Introduction

Micol Cirilli is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on modified release compositions. With a total of 2 patents, his work has the potential to enhance the efficacy of oral medications.

Latest Patents

Micol Cirilli's latest patents include innovative pharmaceutical compositions for oral administration comprising deferiprone. The first patent discloses modified release tablets that are suitable for either twice daily or once daily administration. This formulation aims to improve patient compliance and therapeutic outcomes. The second patent also focuses on modified release pharmaceutical formulations, specifically coated tablets that exhibit modified release properties when administered as whole or half tablets. This invention is designed for twice daily oral administration, further showcasing Cirilli's commitment to advancing pharmaceutical technology.

Career Highlights

Throughout his career, Micol Cirilli has worked with prominent organizations such as Chiesi Farmaceutici S.p.a. and Università Degli Studi Di Milano. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in pharmaceutical sciences.

Collaborations

Micol Cirilli has collaborated with notable colleagues, including Marisa Pertile and Andrea Gazzaniga. These partnerships have facilitated the development of innovative solutions in the pharmaceutical industry.

Conclusion

Micol Cirilli's contributions to pharmaceutical formulations, particularly in modified release technologies, highlight his role as an influential inventor in the field. His work continues to pave the way for advancements in medication delivery systems.